Worth Asset Management’s Sabra Healthcare REIT SBRA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-350
Closed -$4.12K 361
2023
Q2
$4.12K Sell
350
-150
-30% -$1.71K ﹤0.01% 374
2023
Q1
$5.75K Sell
500
-600
-55% -$7.42K ﹤0.01% 363
2022
Q4
$13.7K Hold
1,100
0.01% 281
2022
Q3
$14K Sell
1,100
-2,300
-68% -$34K 0.01% 251
2022
Q2
$47K Hold
3,400
0.03% 205
2022
Q1
$44K Buy
+3,400
New +$46.5K 0.03% 219

Other funds holding SBRA

Worth Asset Management's SBRA Position: Q3 2023 in Review

Worth Asset Management sold out of Sabra Healthcare REIT (SBRA) in Q3 2023, closing a stake of 350 shares — an estimated $4.12K sold.

Worth Asset Management first reported a position in SBRA in Q1 2022 and held it in 6 quarters. The position peaked at $47K in Q2 2022. 329 funds tracked by Wall St. Rank hold SBRA as of Q3 2023.

  • Worth Asset Management reported no remaining Sabra Healthcare REIT position as of Q3 2023 after selling out during the quarter.
  • Worth Asset Management sold 350 Sabra Healthcare REIT shares in Q3 2023, an estimated $4.12K.
  • Worth Asset Management first reported a position in Sabra Healthcare REIT in Q1 2022 and held it in 6 quarters.
  • Worth Asset Management's Sabra Healthcare REIT position peaked at $47K in Q2 2022.
  • 329 funds tracked by Wall St. Rank held Sabra Healthcare REIT as of Q3 2023.

Based on Worth Asset Management's 13F filing for Q3 2023, filed 11 Oct 2023.